A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg/kg vs. 60 mg/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil.

• Váldodahkkit: Piero L Olliaro (Dahkki), Michel T Vaillant (Dahkki), Vincente J Belizario (Dahkki), Nicholas J S Lwambo (Dahkki), Mohamed Ouldabdallahi (Dahkki), Otavio S Pieri (Dahkki), Maria L Amarillo (Dahkki), Godfrey M Kaatano (Dahkki), Mamadou Diaw (Dahkki), Analucia C Domingues (Dahkki), Tereza C Favre (Dahkki), Olivier Lapujade (Dahkki), Fabiana Alves (Dahkki), Lester Chitsulo (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Public Library of Science (PLoS), 2011-06-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Praziquantel at 40 mg/kg in a single dose is the WHO recommended treatment for all forms of schistosomiasis, but 60 mg/kg is also deployed nationally.Four trial sites in the Philippines, Mauritania, Tanzania and Brazil enrolled 856 patients using a common protocol, who were randomised to receive pra...